On Friday, April 9, ASCO and Friends of Cancer Research (Friends) co-hosted a live virtual event, which brought together experts from across the healthcare sector to discuss the recent release of the new ASCO-Friends recommendations for modernizing eligibility criteria to improve patient access and representation in cancer clinical trials. ASCO-Friends recommendations address five specific areas:…
At a Senate briefing hosted by Friends of Cancer Research (Friends), a panel comprised of leading stakeholders convened to discuss changes in cancer care and criticisms of the U.S. Food and Drug Administration’s (FDA) expedited approval programs. As recent advancements to discover and develop targeted therapies, immunomodulating agents, and cell-based therapies provide new and potentially…
Jim Omel is a myeloma patient and a cancer research advocate. He spoke at the 2017 Friends of Cancer Research Annual Meeting and was an author of the panel 2 whitepaper, Data Generation to Support Cross-Labeling of Indications for Combination Products. Below are his abridged remarks from the meeting. To view his remarks in full,…
With summer now behind us, we thought it would be a good time to reflect on one of the special experiences our science policy analyst, Diana Merino, had over the summer… This summer, for the second year in a row, I got to spend a week volunteering at Camp Fantastic, a camp that provides an…
Friends of Cancer Research Vice President – Public Affairs, Ryan Hohman, shares why he is passionate about the Friends mission of bringing life-saving treatments to patients in the fastest and safest way possible in the latest installment of “My Story.” From a young age, Ryan has been witness to how cancer impacts families and saw what he…
In November 2014, assistant professor, Jenna Kieckhaefer, was diagnosed with breast cancer. She was only 28 years old at the time. The concept of having breast cancer first came to Jenna’s attention when she was working on her PhD. She went for an annual visit and was informed she had lumpy breasts. While the doctor…
David Baltimore is a world-renowned biologist who in 1975 won the Nobel Prize in physiology or medicine along with Howard Temin and Renato Dulbecco “for their discoveries concerning the interaction between tumor viruses and the genetic material of the cell.” We had the chance to sit down and discuss science, cancer research, and more with…
In the second installment of the “My Story” series, Friends President & CEO, Jeff Allen, PhD, recounts his personal experience with cancer from a young age when his grandfather was sick with the disease and why he is motivated for working in this field. With a background in cancer research focused upon molecular changes associated with cancer…
A father. A husband. A multiple myeloma patient. David Mitchell refuses to let his cancer diagnosis define him. Watch below as he discusses his journey as a patient, why he feels lucky every day, and how the work we do at Friends is critical for patients like himself.
As part of Pfizer’s ongoing “Pfizer Partnerships” video series, Friends of Cancer Research Founder and Chairperson Ellen Sigal discussed the structure and promise of the Lung-MAP clinical trial. “Lung-MAP is about collaboration of all sectors working towards a common goal, and that’s to help patients with squamous cell lung cancer,” said Dr. Sigal. “It’s about…
